Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’ - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Journal of Internal Medicine Année : 2016

Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’

1 Laboratory of Alzheimer's Neuroimaging & Epidemiology, Saint John of God Clinical Research Centre, Brescia
2 UNIROMA - Università degli Studi di Roma "La Sapienza" = Sapienza University [Rome]
3 IRCCS-Hospital San Raffaele Pisana of Rome and Cassino
4 Department of Neuroscience, Mario Negri Institute for Pharmacological Research, Milan
5 Department of Psychiatry and Clinical Psychobiology, Faculty of Medicine, University of Barcelona and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
6 INS - Institut de Neurosciences des Systèmes
7 UNIPG - Università degli Studi di Perugia = University of Perugia
8 Department of Psychiatry and Psychotherapy, Faculty of Medicine
9 UniGe - Università degli studi di Genova = University of Genoa
10 Leipzig University / Universität Leipzig
11 UNITN - Università degli Studi di Trento = University of Trento
12 Alzheimer Center Amsterdam
13 Department of Gerontology, Neurosciences & Orthopedics, Catholic University, Rome
14 Alzheimer's Disease Unit and Other Cognitive Disorders Unit, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona
15 ToNIC - Toulouse NeuroImaging Center
16 SDN Istituto di Ricerca Diagnostica e Nucleare, Napoli
17 CRMBM - Centre de résonance magnétique biologique et médicale
18 CEMEREM - Centre d'Exploration Métabolique par Résonance Magnétique [Hôpital de la Timone - APHM]
19 Third Neurologic Clinic, Medical School, G. Papanikolaou Hospital, Aristotle University of Thessaloniki, Thessaloniki,
20 Department of Neurology, Alzheimer Centre, VU Medical Centre, Amsterdam
21 GSK - GlaxoSmithKline [Stevenage, UK]
22 LilNCog - Lille Neurosciences & Cognition - U 1172
23 CIC-UPCET - Centre investigation clinique - Unité de pharmacologie clinique et d'évaluations thérapeutiques
24 Laboratory of Neuroimaging of aging, Memory clinic and LANVIE
J. Pariente
P. Payoux

Dates et versions

hal-03500757 , version 1 (22-12-2021)

Identifiants

Citer

S. Galluzzi, M. Marizzoni, C. Babiloni, D. Albani, L. Antelmi, et al.. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a ‘European ADNI study’. Journal of Internal Medicine, 2016, 279 (6), pp.576-591. ⟨10.1111/joim.12482⟩. ⟨hal-03500757⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More